Clinicopathological impact of the interaction between megakaryocytes and myeloid stroma in chronic myeloproliferative disorders: A concise update

Leukemia and Lymphoma

Volumn 24, Issue 5-6, 1997, Pages 463-481

  Thiele, Juergen ^a   Kvasnicka, Hans Michael ^a   Fischer, Robert ^a   Diehl, Volker ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chronic myeloid leukemia; Idiopathic (primary) myelofibrosis; Megakaryocytes; Myelofibrosis; Myelofibrosis progression index; Prognostic impact; Transendothelial migration

Indexed keywords

BUSULFAN; COLLAGEN TYPE 4; INTERFERON; RETICULIN;

BONE MARROW CELL; CANCER STAGING; CHRONIC MYELOID LEUKEMIA; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MEGAKARYOCYTE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STROMA;

EID: 0030965583     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709055584     Document Type: Review

References (151)

1. Bentley, S. A. (1982). Bone marrow connective tissue and the haematopoietic microenvironment. Br. J. Haematol., 50, 1-6.
2. McCarthy, D. M. (1985). Fibrosis of the bone marrow: Content and causes. Br J. Haematol, 59, 1-7.
3. Lewis, S. M. (1985). Myelofibrosis: Historical perspective. In: Myelofibrosis, Pathophystology and Clinical Management, edited by S. M. Lewis, (New York: Marcel Dekker) pp. 1-13.
4. Charron, D., Robert, L., Couty, M. C. and Binet, J. L. (1979). Biochemical and histological analysis of bone marrow collagen in myelofibrosis. Br. J. Haematol., 41, 151-61.
5. Gay, S., Gay, R. E. and Prchal, J. T. (1984). Immunohistological studies of bone marrow collagen. In: Myelofibrosis and the Biology of Connective Tissue, edited by P. Berk, H. Castro-Malaspina, and L. Wasserman, (New York: Alan R. Liss). pp. 291-306.
6. Apaja-Sarkkinen, M., Autio-Harmainen, H., Alavaikko, M., Risteli, J. and Risteli, L. (1986). Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis. Br. J. Haematol., 63, 571-580.
7. Reilly, J. T., Nash, J. R. G., Mackie, M. J. and McVerry, B. A. (1985). Endothelial cell proliferation in myelofibrosis. Br. J. Haematol., 60, 625-630.
8. Lisse, I., Hasselbach, H. and Junker, P. (1991). Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases. An immunohistological study. APMIS, 99, 171-178.
9. Reilly, J. T., Nash, J. R. G., Mackie, M. J. and McVerry, B. A. (1985). Immuno-enzymatic detection of fibronectin in normal and pathological tissue. Br. J. Haematol., 59, 497-504.
10. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H. and Fauci, A. S. (1986). Transforming growth factor lype β. Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA, 83, 4167-4171.
11. Hasselbach, H. (1990). On the pathogenesis of angiogenesis in idiopathic myelofibrosis Am. J. Hematol., 33, 151.
12. Thiele, J., Rompcik, V., Wagner, S. T. and Fischer, R (1992). Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia vera: An immunomorphometric study on trephine biopsies of the bone marrow. Br. J. Haematol., 80, 227-234.
13. Burkhardt, R., Bartl, R., Jaeger, K., Frisch, B., Kettner, G., Mahl, G. and Sund, M. (1984). Chronic myeloproliferative disorders (CMPD). Path. Res. Pract., 179, 131-186.
14. Frisch, B. and Bartl, R. (1985). Histology of myelofibrosis and osteomyelosclerosis. In: Myelofibrosis, Pathophysiology and Clinical Management, edited by S. M. Lewis, (New York' Marcel Dekker) pp 51-86.
15. Georgii, A., Vykoupil, K. F., Buhr, T., Choritz, H., Döhler, U., Kaloutsi, V. and Werner, M. (1990). Chronic myeloproliferative disorders in bone marrow biopsies. Path. Res. Pract., 186, 3-27.
16. Buhr, T., Georgii, A. and Choritz, H. (1993). Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification. Path. Res. Pract., 189, 121-132.
17. Bartl, R., Frisch, B. and Wilmanns, W. (1993). Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur J. Haematol., 50, 41-52.
18. Dickstein, J. I. and Vardiman, J. W. (1993). Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am. J. Clin. Pathol., 99, 513-525
19. Adamson, J. W. and Fialkow, P. J. (1978). The pathogenesis of myeloproliferative disorders. Br J Haematol., 38, 299-303.
20. Jacobson, R. J. Salo, A. and Fialkow, P. J. (1978). Agnogenic myeloid metaplasia: A clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood, 51, 189-94.
21. Groopman, J. E. (1980) The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann. Intern. Med., 92, 857-858.
22. Huang, S. and Terstappen, L. W. (1992). Formation of hematopoietic microenviroment and haematopietic stem cells from single human bone marrow stem cells. Nature, 360, 745-749.
23. 1-positive chronic myelogenous leukemia. Blood, 51, 1039-1044.
24. Golde, D. W., Hocking, W. G., Quan, S. G., Sparkes, R. S. and Gale, R. P. (1980). Origin of human bone marrow fibroblasts. Br. J. Haematol., 44, 183-187.
25. Castro-Malaspina, H., Gay, R. E., Resnick, G., Kapoor, N., Meyers, P., Chiarieri, D., McKenzie, S, Broxmeyer, H. E. and Moore, M. A. S. (1980). Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood, 56, 289-301.
26. Greenberg, B. R., Woo, L., Veomett, I. C., Payne, C. M. and Ahmann, F. R (1987). Cytogenetics of bone marrow fibroblastic cells in idiopathic chronic myelofibrosis. Br. J. Haematol., 66, 487-490.
27. O'Brian, S., Kantarjan, H, Shtalrid, M., Blick, M., Beran, M. and Talpaz, M. (1988). Lack of cluster region rearrangement in marrow fibroblasts of patients with Philadelphia chromo- some-positive chronic myelogenous leukemia. Hematol. Pathol., 2, 25-29.
28. Wang, J. C., Lang, H. D., Lichter, S., Weinstein, M. and Benn, P. (1992). Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. Br. J. Haematol., 80, 184-188.
29. Waller, E. K., Olweus, J., Lund-Johansen, F, Huang, S., Nguyen, M., Guo, G. R. and Terstappen, L (1995). The "common stem cell" hypothesis reevalualed: Human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. Blood, 85, 2422-2435.
30. Bhatia, R., McGlave, P. M., Dewald, G. W., Blazar, B. R. and Verfaillie, C. M. (1995). Abnormal function of the bone marrow microenviroment in chronic myelogenous leukemia: Role of malignant stromal macrophages Blood, 85, 3636-3645.
31. Castro-Malaspina, H. (1984). Pathogenesis of myelofibrosis: Role of ineffective megakaryoporesis and megakaryocyte components. In: Myelofibrosis and the Biology of Connective Tissue, edited by P. Berk, H. Castro-Malaspina, and L. Wasserman, (New York: Alan R Liss), pp. 427-454
32. Reilly, J. T. (1992). Pathogenesis of idiopathic myelofibrosis: Role of growth factors. J. Clin Pathol., 45, 461-464.
33. Kimura, A., Katoh, O., Hyodo, H., Kuramoto, A., Satow, Y. (1995) Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia. Leukemia Lymphoma, 18, 237-242.
34. Hiti-Harper, J., Wohl, H. and Harper, E. (1978). Platelet factor 4: An inhibitor of collagenase. Science, 199, 991-992.
35. Chernoff, A., Levine, R. F. and Goodman, D. S. (1979). Origin of platelet-derived growth factor in megakaryocytes in guinea pigs J Clin Invest., 65, 926-930.
36. Scher, C. D., Shepard, R. C., Antoniades, H N. and Stiles, C. D. (1979). Platelet-derived growth factor and the regulation of the mammalian fibroblast cell cycle. Biochim Biophys. Acta. 560, 217-241.
37. Burstein, S A., Malpass, T. W., Yee, E., Kadin, M, Bridgen, M., Adamson, J. W. and Marker, L. A (1984). Platelet factor 4-excretion in myeloproliferative disease: Implications for the aetiology of myelofibrosis. Br. J. Haematol., 57, 383-392.
38. Assoian, R, K., Grotendorst, G. R., Miller, D. M. and Sporn, M. B. (1984). Cellular transformation by coordinated action of three peptide growth factors from human platelets Nature, 309, 804-806.
39. Castro-Malaspina, H., Rabellino, E., Yen, A., Nachman, R. L. and Moore, M A. S. (1981). Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood. 57, 781-787.
40. Bernabei, P A., Arcangeli, A., Casini, M., Grossi. A., Padovani, R. and Rossi Ferrirn, P (1992). Platelet-derived growth factor(s) mitogenic activity in patients with myeloproliferative disease. Br. J. Haematol., 63, 353-357.
41. Kimura, A., Katoh, O. and Kuramoto, A. (1988). Effects of platelet-derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblasts. Br. J. Haematol., 69, 9-12.
42. Katoh, O., Kimura, A. and Kuramoto, A. (1988). Platelet-derived growth factor is decreased in patients with myeloproliferative disorders. Am. J. Hematol., 27, 276-280.
43. Baglin, T. P., Price, S. M and Boughton, B. J. (1988). A reversible defect of platelet PDGF content in myeloproliferative disorders. Br J. Haematol., 69, 483-486.
44. Kimura, A., Katoh, O., Hyodo, H. and Kuramoto, A. (1989). Transforming growth factor-β regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br. J. Haematol., 72, 486-491.
45. Katoh, O., Kimura, A., Itoh, T. and Kuramoto, A. (1990). Platelet derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders. Am. J. Hematol, 35, 145-150.
46. Rueda, F, Piñol, G., Marti, F. and Pujol-Moix, N. (1991). Abnormal levels of platelet-specific proteins and mitogenic activity in myeloproliferative disease. Acta Haematol., 85, 12-15.
47. Martyré. M. C. (1991). Platelet PDGF and TGF: Levels in myeloproliferative disorders. Leukemia Lymphoma, 6, 1-6.
48. Kimura, A, Nakata, Y., Hyodo, H., Kuramoto, A. and Satow, Y. (1994). Platelet-derived growth factor expression in accelerated and blastic phase of chronic myelogeneous leukaemia with myelofibrosis. Br. J. Haematol., 86, 303-307.
49. Martyré, M. C., Romquin, N., Bousse-Kerdiles, M. C., Chewillard, S., Benyahia, B., Dupriez, B., Demory, J. L. and Bauters, F. (1994) Transforming growth factor-β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br. J. Haematol., 88, 9-16.
50. Maryré M. C. (1995). TGF-β and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leukemia Lymphoma, 20, 39-44.
51. Wickenhauser, C., Hillienhof, A., Jungheim, K., Lorenzen, J., Ruskowski, H., Hansmann, M.-L., Thiele, J. and Fischer, R. (1995). Detection and quantification of transforming growth factor β (TGF-β) and platelet derived growth factor (PDGF) release by normal human megakaryocytes. Leukemia,9, 310-315.
52. Wickenhauser, C., Lorenzen, J., Thiele, J., Hillienhof, A., Jungheim, K., Schmitz, B., Hansmann, M.-L. and Fischer, R. (1995). Secretion of cytokines (interleukins-lα, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes. Blood, 85, 685-691.
53. Schmitz, B., Thiele, J., Kaufmann, R., Witte, O., Wickenhauser, C., Kuhn-Regnier, F. and Fischer, R. (1995). Megakaryocytes and fibroblasts-interactions as determined in normal human bone marrow specimens. Leukemia Res., 19, 629-637.
54. Schmitz, B., Thiele, J., Witte, O., Kaufmann, R., Wickenhauser, C., Fischer, R. (1995). Influence of cytokines (IL-lα, IL-3, IL-11, GM-CSF) on megakaryocyte-fibroblast interactions in normal human bone marrow. Eur. J. Haematol., 55, 24-32.
55. Kimura, A, Katoh, O., Hyodo, H., Kusumi, S., Kuramoto, A. (1991). Autocrinie and/or paracrine meachnism operate during the growth of human bone marrow fibroblasts. Br. J. Haematol., 78, 469-473.
56. Singal, R. and Belliveau, R. R. (1988). Quantification of megakaryocytes in normal bone marrow. Analyt. Quant. Cytol Histol., 10, 33-36.
57. Lazzarino, M., Morra, E., Castello, A., Inverardi, D., Coci, A., Pagnuco, G., Magrini, U., Zei, G. and Bernasconi, C. (1986). Myelofibrosis in chronic granulocytic leukemia. Br. J. Haematol., 64, 227-240.
58. Burkhardt, R. (1988). Bone marrow in megakaryocytic disorders. Hematol. Oncol. Clin. N. Am, 2, 695-733.
59. Kaloutsi, V., Fritsch, R. S., Buhr, T., Restrepo-Specht, I., Widjaja, W. and Georgii, A. (1991). Megakaryocytes in chronic myeloproliferative disorders: Numerical density correlated between different entities. Virchows Archiv A Pathol. Anat., 418, 493-497
60. Thiele, J., Hoeppner, B., Zankovich, R. and Fischer, R. (1989). Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia) - correlations, between clinical and morphological features. Virchows Archiv A Pathol. Anat, 415, 191-202.
61. Thiele, J., Wienhold, S., Zankovich, R. and Fischer, R. (1990). A histomorphometric analysis of trephine biopsies of bone marrow from 65 patients with chronic myeloid leukemia. Classification of patients into subgroups with different survival patterns. Analyt. Quant. Cytol. Histol., 12, 103-116
62. Gatter, K. C., Cordell, J. L., Turley, H., Heryet, A., Kiefer, N., Anstee, D. J. and Mason, D. J. (1988). The immunohistological detection of platelet, megakaryocytes and thrombi in routinely processed specimens. Histopathology 13, 257-267.
63. Thiele, J. and Fischer, R. (1991). Megakaryocytopoiesis in haematological disorders: Diagnostic features of bone marrow biopsies Virchows Archiv A Pathol. Anat., 418, 87-97.
64. Thiele, J., Kvasnicka, H. M., Titius, B. R, Parpert, U., Nebel, R., Zankovich, R., Dienemann, D., Stein, H., Diehl, V. and Fischer, R. (1993). Histological features of prognostic significance in CML-an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow. Ann. Hematol., 66, 291-302.
65. Thiele, J., Kvasnicka, H. M., Niederle, N., Zirbes, T. K., Schmidt, M., Dammasch, J., Meuter, B. R, Leder, L.-D., Kloke, O., Diehl, V. and Fischer, R. (1995). The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML-a comparative morphometric study on sequential trephine biopsies. Ann. Hematol, 70, 121-128.
66. Kvasnicka, H. M., Thiele, J., Amend, T. and Fischer R. (1994). Three-dimensional (3D) reconstruction of histological structures in human bone marrow from serial sections of trephine biopsies The stereological appearance of sinusoidal vessels in primary (idiopathic) osteomyelofibrosis. Analyt. Quant. Cytol. Histol., 16, 159-166.
67. Thiele J., Titius, B. R., Kopsidis, C. and Fischer, R. (1992). Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: A critical evaluation by immunohistochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes. Virchows Archiv B Cell Pathol., 62, 275-282.
68. Dekmezian, R., Kantarjian, H. M., Keating, M., Talpaz, M., McCredie, K. B and Freireich, E. J. (1987) The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer. 57, 1739-1743.
69. Lohmann, T. B. and Beckman, E. N. (1983). Progressive myelofibrosis in agnogenic myeloid metaplasia. Arch. Pathol. Lab. Med., 107, 593-594.
70. Manoharan, A. and Pitney, W. R. (1984). Chemotherapy resolves symptoms and reverses fibrosis in myelofibrosis. Scand. J. Haematol., 33, 453-459.
71. Charbord, P., Neel, H, Caillou, B, Kahn, E. and Parmentier, C. (1984). Effect of alkylating agents on hematopoiesis in myelofibrosis. Nouv. Rev. Fr. d'Hématol., 26, 361-369.
72. Wolf, B. C. and Neiman, R. S. (1985). Myelofibrosis with myeloid metaplasia: Pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood, 65, 803-809.
73. Ellis, J. T., Peterson, P., Geller, S. A. and Rappaport, H. (1989). Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin. Hematol., 23, 144-155.
74. Thiele, J., Simon, K. G., Fischer, R. and Zankovich, R. (1988). Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical courses in 40 patients. Pathol. Res. Pract, 183, 434-445
75. Löfvenberg, E., Wahlin, A. Roos, G., Öst, Å. (1990). Reversal of myelofibrosis by hydroxyurea. Eur. J. Haematol., 44, 33-38.
76. Hasselbach, H. and Lisse, I. (1991). A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis. Em: J. Haematol., 46, 285-289.
77. Buhr, T., Choritz, H. and Georgii, A. (1992). The impact of megakaryocyte proliferation for the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukemia. Virchows Archiv A Pathol. Anal., 420, 473-478.
78. Thiele, J., Chen, Y. S., Kvasnicka, H. M., Diehl, V. and Fischer, R. (1994). Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyeloflbrosis a histomorphometric study on sequential trephine biopsies. Leukemia Lymphoma, 14, 163-169.
79. Mc Glave, P. B., Brunning, R. D., Hurd, D. D. and Kim, T. H. (1982). Reversal of severe bone marrow fibrosis and osteosclerosis following allogeneic bone marrow transplantation for chronic granulocyte leukaemia. Br. J. Haematol., 52, 189-194.
80. Oblon, D. J, Elvenbein, G. J., Braylam, R. C., Jones, J. and Weiner, R. S. (1983). The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation. Exp. Hematol., 11, 681-685.
81. Dokal, I., Jones. L., Deenmamode, M., Lewis, S. M. and Goldman, J. M. (1989). Allogeneic bone marrow transplantation for primary myelofibrosis. Br. J. Haematol., 71, 158-159.
82. Ifrah, N., Gardembas-Pain, M., Hunault, M., Saint-Andre, J. P., Foussard, C. and Boasson, M. (1989). Allogeneic bone marrow transplantation for primary myelofibrosis. Br. J. Haematol., 73, 575-576.
83. Granstein, R. D., Murphy, G. F., Margolis, R. J., Byrne, M. H. and Amento, E. P. (1987). Gamma-interferon inhibits collagen synthesis in vivo in the mouse. J. Clin. Invest., 79, 1254-1258.
84. Parmeggiani, L., Ferrant, A., Rodhain, J., Michaux, J. L., Sokal, G (1987). Alpha Interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia. Eur. J. Haematol., 39, 228-232.
85. Hasselbalch, H. (1988). Interferon in myelofibrosis. Lancet 1, 355.
86. Barosi, G., Liberato, L. N., Costa, A. and Ascari, E. (1989). Cytoreductive effect of recombinant alpha Interferon in patients with myelofibrosis with myeloid metaplasia. Blut, 58, 271-274.
87. Barosi, G., Liberato, L. N., Costa, A, Buratti, A., Di Dio, F., Salvatore, S. and Ascari, E. (1990). Induction and maintenance alpha-interferon therapy in myelofibrosis with myeloid metaplasia. Eur J. Haematol., 45, 12-14.
88. McCarthy, D., Clark, J. and Giles. F. (1991). The treatment of myelofibrosis with α-interferon. Br. J. Haematol., 78, 590-591.
89. Sacchi, S. (1995). The role of a α-interferon in essential thrombocythaemia. polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): A concise update. Leukemia Lymphoma, 19, 13-20.
90. Bauermeister, D. E (1971). Quantification of bone marrow reticulin: A normal range. Am. J. Clin. Pathol., 56, 24-31.
91. Beelen, D. W., Graeven, U., Elmaagacli, A. H., Niederle, N., Kloke, O., Opalka, B. and Schaefer, W. (1995). Prolonged administration of interferon-α in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome Blood, 36, 2981-2990.
92. Branehög, I., Ridell, B., Swolin, B. and Weinfeld, A. (1975). Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythemia and allied diseases. Scand. J. Haematol., 15, 321-332.
93. Thiele, J., Zankovich, R., Schneider, G., Kremer, B., Fischer, R. and Diehl, V. (1988). Primary (essential) thrombocythemia versus polycythemia vera rubra A histomorphometric analysis of bone marrow features in trephine biopsies. Analyt. Quant. Cytol. Histol. 10, 375-382.
94. Nafe, R., Kaloutsi, V., Fritsch, R. S. and Georgii, A. (1990). Quantitative cytomorphology of megakaryocytes in chronic myeloproliferative disorders-Analysis of planimetric and numeric characteristics by means of a knowledge based system. Exp. Pathol., 40, 213-219.
95. Nafe, R., Georgii. A., Kaloutsi, V., Fritsch, R. S. and Choritz, H. (1991). Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders. Virchows Archiv B Cell Pathol., 61, 111-116.
96. Thiele, J., Wagner, S., Bertsch. H. P., Wienhold, S. and Fischer, R. (1990). Pro-megakaryoblasts in bone marrow tissue from patients with primary (idiopathic) osteo-myelofibrosis (agnogenic myeloid metaplasia). Path. Res. Pracr., 186, 586-596.
97. Thiele, J., Wagner, S., Degel, C., Dienemann, D., Wienhold, S., Zankovich, R., Fischer, R and Stein, H. (1990). Megakaryocyte precursors (pro- and megakaryoblasts) in bone marrow tissue from patients with reactive thrombocytosis, polycythemia vera and primary (essential) thrombocythemia. An immunomorphometric study. Virchows Archiv B Cell Pathol., 58, 295-302
98. Thiele, J., Wagner, S, Weuste, R., Dienemann, D, Wienhold, S., Zankovich, R., Fischer, R and Stein, H. (1990). An immunomorphometric study on megakaryocyte precursor cells in bone marrow tissue from patients with chronic myeloid leukemia (CML). Eur. J. Haematol., 44, 63-70.
99. Thiele, J., Hoefer, M., Kvasnicka, H. M., Bertsch, H. P., Zankovich, R. and Fischer, R. (1993). Erythropoiesis in CML-immunomorphometric quantification, PCNA-reactivity, and influence on survival. Hematol. Pathol., 7, 239-249.
100. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A G., Gralnick, H. R. and Sultan, C (1985). Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British cooperative group. Ann. Intern. Med., 103, 460-462.
101. Den Ottolander, G. J, Velde, J, Brederoo, P., Geraedts, J. P. M., Slee, P. H. T., Willemze, R., Zwaan, F. E., Haak, H. L., Muller, H. P. and Bieger, R. (1979). Megakaryoblastic leukaemia (acute myelofibrosis): A report of three cases. Br. J. Haematol., 42, 9-20.
102. Bain, B. J, Catovsky, D., O'Brien, M., Prentice, H. G., Lawlor, E., Kumaran, T. O., McCann, S. R., Matutes. E. and Galton, D. A. G. (1981). Megakaryoblastic leukemia presenting as acute myelofibrosis - a study of four cases with the platelet-peroxidase reaction. Blood, 58, 206-213.
103. Huang, M. J., Li, C. Y., Nichols, W. L., Young, J. H. and Katzmann, J. A. (1984). Acute leukemia with megakaryocytic differentiation. A study of 12 cases identified immunocytochemically. Blood, 64, 427-439.
104. Hruban, R. H., Kuhajda, F. P. and Mann, R. B. (1987). Acute myelofibrosis. Am. J. Clin. Palhol., 88, 578-588.
105. Ribeiro, R. C., Oliveira, M. S. P., Fairclough, D., Hurwitz, C., Mirro, J., Behm, F. G., Head, D., Silva, M. L. M., Raimondi, S. C., Crist, W M and Krance, R. (1993). Acute megakary-oblastic leukemia in children and adolescents: A retrospective analysis of 24 cases. Leukemia Lymphoma, 10, 299-306.
106. Terui, T., Niitsu, Y., Mahara, K., Fujisaki, Y., Urushizaki, Y., Kohgo, Y, Watanabe, N., Ogura, M, and Saito, H. (1990). The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implication in myelofibrosis. Blood, 75, 1540-1548.
107. Reilly, J. T., Barnett, D., Dolan, G., Forrest, P., Eastham, J. and Smith, A. (1993). Characterization of an acute micromegakaryocytic leukaemia: Evidence for the pathogenesis of myelofibrosis. Br. J. Haematol., 83, 58-62.
108. Cervantes, F. and Rozman, C. (1982). A multivariate analysis of prognostic factors in chronic myeloid leukemia. Blood, 60, 1298-1304.
109. Sokal, J. E., Cox, E. B., Baccarani, M, Tura, S., Gomez, G. A., Robertson, J. D., Tso, C. Y., Braun, T J., Clarkson, B. D., Cervantes, F. and Rozman, C. The Italian Cooperative CML Study Group. (1984). Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood, 63, 789-799.
110. Kantarjian, H. M., Smith, T. L., McCredie, K. B., Keating, M. J., Walters, R. S., Talpaz, M., Hester, J. P., Bligham, G., Gehan, E. and Freireich, E. J. (1985). Chronic myelogenous leukemia A multivariate analysis of the associations of patient characteristics and therapy with survival. Blood, 66, 1326-1335
111. Sokal, J. E., Baccarani, M., Russo, D. and Tura, S. (1988). Staging and prognosis in chronic myelogenous leukemia. Semin. Hemalol, 25, 49-61.
112. Kantarjian, H., Keating, M. J., Smith, T. L., Talpaz, M. and McCredie, K. B. (1990) Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. Am. J. Med., 88, 1-8.
113. The Italian Cooperative Study Group On Chronic Myeloid Leukemia. (1991). Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia - the value of early evaluation of the course of the disease. Ann. Hematol., 63, 307-314.
114. Kantarjian, H. M., Deisseroth, A, S., Kurzrock, R., Estrov, Z. and Talpaz, M. Chronic myelogenous leukemia: a concise update. Blood, 82, 691-703.
115. Hehlmann, R., Heimpel, H., Hasford, J, Kolb, H. J., Pralle, H., Hossfeld, D. K. and the German CML Study Group. (1994). Randomized comparison of interferon-α with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood, 84, 4064-4077.
116. Morra, E., Lazzarino, M., Alimena, G., Liberati, A. M., Grignani, F., Mandelli, F. and Bernasconi, C. (1992). The rote of Interferon in the treatment of chronic myelogenous leukemia: Results and prospects. Leukemia Lymphoma, 6, 305-315.
117. Ozer, H., George, S. L., Schiffer, C. A., Rao, K., Rao, P. N., Wurster-Hill, D. H., Arthur, D. D., Powell, B., Gottlieb, A., Peterson, B. A., Rai, K., Testa, J. R., LeBeau, M., Tantravahi, R. and Bloomfield. C. D. (1993) Prolonged subcutaneous administration of recombinant α2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: Effect on remission duration and survival: Cancer and Leukemia Group B Study 8583. Blood, 82, 2975-2984.
118. Niederle, N., Kloke, O., Wandl, U. B., Becher, R., Moritz, T. and Opalka, B. (1993). Long-term treatment of chronic myelogenous leukemia with different interferons: Results from three studies. Leukemia Lymphoma, 9, 111-119.
119. The Italian Cooperative Study Group On Chronic Myeloid Leukimia. (1994). Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic mycloid leukemia. N. Engl. J. Med., 330, 820-825.
120. Kantarjian, H. M., Smith, T. L., O'Brien, S., Beran, M., Pierce, S, Talpaz, M. and The Leukemia Service. (1995). Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-α therapy. Ann. Intern. Med., 122, 254-261.
121. Allan, N. C., Richards, S. M., Shepherd, P. C. A., on behalf of the UK Medical Research Council's Working Panics for Therapeutic Trials in Adult Leukaemia. (1995). UK Medical Researche Council randomised, multicentre trial of interferon-αnl for chronic myeloid leukaemia: improved survival irrespective of cytogenic response. Lancet, 345, 1392-1397.
122. Gralnick, H. R., Harbor, J. and Vogel, C. (1971). Myelofibrosis in chronic granulocytic leukemia. Blood, 37, 152-162.
123. Byssens, N. and Bourgeois, N. H. (1977) Chronic myelocytic leukemia versus idiopathic myelofibrosss. A diagnostic problem in bone marrow biopsies. Cancer. 40, 1548-1561
124. Clough, V., Geary, C. G., Hashimi, K., Davson. G. and Knowlson, T. (1979). Myelofibrosis in chronic granulocytic leukaemia. Br. J. Haematol., 42, 515-526.
125. Thiele, J., Kvasnicka, H. M., Zankovich, R., Fischer, R. and Diehl, V. (1991). Parameters of predictive value in CML-the prognostic impact of histopathological variables in a multivariate regression analysis. Leukemia Lymphoma, 4, 63-74.
126. Thiele, J., Kvasnicka, H. M., Niederle, N., Koke, O., Schmidt, M., Lienhard, H., Zirbes, T., Mcuter, R. B., Leder, L. D. and Fischer, R (1995). Clinical and hissological features retain their prognostic impact under interferon therapy of CML: A pilot study. Am. J. Hematol., 50, 30-39.
127. Lorand-Metze, I., Vasallo, J. and Souza, C. A. (1987). Histological and cytoiogical heterogeneity of bone marrow in Philadelphia-positive chronic myelogenous leukaemia at diagnosis. Br J. Haematol., 67, 45-49.
128. Lorand-Metze, I. (1989). Bone marrow morphology at diagnosis as a prognostic parameter in Philadelphia-positive chronic myelogenous leukaemia (CML). Br. J. Haemarol., 71, 163.
129. Charbord, P. (1989). Increased vascularity of bone marrow in myelofibrosis. Br. J. Haemarol., 62, 595-596.
130. Van Dyke, D., Anger, H. O., Parker, H., McRae, J., Dobson, E. L., Yano, Y., Naets, J. P. and Linfoot, J. (1971). Markedly increased bone blood flow in myelofibrosis. J. Nucl. Med., 72, 506-512.
131. Miyazono, K., Okabe, T, Urabe, A., Takaku, F. and Heldin, C. H. (1987). Purification and properties of an endothelial cell growth factor from human platelets. J. Biol. Chem., 262, 4098-4103.
132. Folkman, J. and Klagsbrun, M. (1987). Angiogenic factors. Science, 235, 442-447.
133. Roberts, A. B., Heine, U. I., Flanders, K. C. and Spron, M. B. (1990). Transforming growth facsor-β: Major role in regulation of extracellular matrix. Ann. NY. Acad. Sci, 580, 225-232.
134. Vaughan, J. M. and Harrison, C. V. (1939). Leuco-erythroblastic anaemia and myelosclerosis. J. Pathol. Bacterial., 48, 339-352.
135. Partanen, S, Ruutu, T. and Vuopio, P. (1982). Circulating haematopoietic progenitors in myelofibrosis. Scand. J. Haematol., 29, 325-330.
136. Hibbin, J. A., Njoku, O. S., Matutes, E., Lewis, S. M. and Goldman, J. M. (1984). Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br. J. Haematol., 57, 495-503.
137. Grossi, A, Vannuchi, A. M., Rafanelli, D., Vannucchi. L. and Ferrini, P. R (1987). Megakaryocyte progenitors in the bone marrow and peripheral blood of patients with myeloproliferative diseases. Am. J. Hematol., 25, 371-376.
138. Han, Z. C., Briere, J., Nedellec, G., Abgrall. J. F, Sensebe, L-. Parent, D. and Guern, G. (1988). Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis. Eur. J. Haemtol., 40, 130-135.
139. Wolf, B.C and Neiman, R. S. (1987). Hypothesis: Splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hematol. Pathol., 1, 77-80.
140. Falk, S., Mix. D. and Stutte, H J. (1990). The spleen in osteomyelofibrosis. A morphological and immunohistochemical study of 30 cases. Virchows Archiv A Pathol Anat., 416, 437-442.
141. O'Keane, J. C., Wolf, B C. and Neiman, R. S. (1989). The pathogenesis of splenic extramedullary hematopoiesis in metastatic carcinoma. Cancer, 63, 1539-1543.
142. Thiele, J., Klein, H., Falk, S., Bertsch, H P., Fischer, R. and Stutte, H. J. (1992). Splenic megakaryocytopoiesis in primary (idiopathic) osteomyelofibrosis. Acta Haematol., 87, 176-180
143. Lichtman, M. A., Chamberlain, J. K., Simon, W. and Santillo, P. A. (1978). Parasinuoidal location of megakary- ocytes in marrow: A determinant of platelet release. Am. J. Hematol., 4, 303-312.
144. Young, K. M. (1989). Localization of megakaryocytes in bone marrow. Blood cells, 15, 15-21.
145. Thiele, J., Kvasnicka, H M., Amend, T. and Fischer, R. (1994). Megakaryocytes and sinus walls in primary osteomyelofibrosis: Transendothelial migration as revealed by three-dimensional reconstruction of serial sections following sequential double-immunostaining. Virchows Archiv, 424, 383-387.
146. Becker, R. P. and DeBruyn. P. P. H. (1976). The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a scanning electron microscopic investigation. Am. J. Anat., 145, 183-206.
147. Tavassoli, M. and Aoki, M. (1981). Migration of entire megakaryocytes through the marrow blood barrier. Br. J. Haematol., 48, 25-29.
148. Melamed, M. R, Clifton, E. E., Mercer, C. and Koss, L. G. (1966). The megakaryocyte blood count. Am. J. Med. Sci., 252, 301-309.
149. Mamatis, A. K. (1969). Megakaryocytes and platelets in central venous and arterial blood. Am. J. Haemtol., 42, 330-335.
150. Hansen, M. and Pedersen, N. T. (1978). Circulating megakaryocytes in blood from the antecubital vein in healthy adult humans. Scand. J. Haematol., 20, 371-376.
151. Pedersen, N. T. (1978). Occurrence of megakaryocytes in various vessels and their retention in the pulmonary capillaries in man. Scand. J. Haematol., 221, 369-375